
Please try another search
Guangzhou Innogen Group Co., Ltd., formerly known as Kunming Yinnuo Pharmaceutical Technology Co., Ltd., engages in the research and development of diabetes drugs. The company was founded in 2014 and is based in Kunming, China. Guangzhou Innogen Group Co., Ltd. operates as a subsidiary of KPC Pharmaceuticals, Inc.
Name | Age | Since | Title |
---|---|---|---|
Ruilin Song | 61 | 2024 | Independent Non-Executive Director |
Fan Jiang | 40 | 2020 | VP, CFO, Secretary to the Board & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review